In the United States, almost one in every four thousand people are diagnosed with an inherited blinding eye disease known as retinitis pigmentosa. Now physician scientists have discovered a brand new way of diagnosing the disease by finding a key marker in a carriers blood and urine that identifies the genetic mutations in a gene held responsible for retinitis pigmentosa. As the procedure is non-invasive, it is a welcoming a breakthrough discovery.
The very first mutation of the gene was first found two years ago after a family asked for intervention to decipher why three of their children had lost their sight from the condition.
RP affects the light sensitive tissue layers at the back of the eye as it degenerates the retina. The new test acts as a most powerful method of assisting in the development of brand new treatments to fight against DHDDS gene mutations.